Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Liabilities and Shareholders Equity (2016 - 2025)

Aethlon Medical filings provide 15 years of Liabilities and Shareholders Equity readings, the most recent being $7.4 million for Q1 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 10.75% to $7.4 million in Q1 2025 year-over-year; TTM through Mar 2025 was $34.1 million, a 27.82% decrease, with the full-year FY2025 number at $7.4 million, down 10.75% from a year prior.
  • Liabilities and Shareholders Equity hit $7.4 million in Q1 2025 for Aethlon Medical, up from $6.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $25.9 million in Q2 2021 to a low of $6.5 million in Q4 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $15.8 million (2023), compared with a mean of $15.4 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 82.0% in 2022 and later crashed 52.9% in 2024.
  • Aethlon Medical's Liabilities and Shareholders Equity stood at $21.9 million in 2021, then fell by 5.44% to $20.7 million in 2022, then tumbled by 49.64% to $10.4 million in 2023, then plummeted by 37.48% to $6.5 million in 2024, then increased by 12.78% to $7.4 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $7.4 million (Q1 2025), $6.5 million (Q4 2024), and $8.8 million (Q3 2024) per Business Quant data.